BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 26, 2014
View Archived Issues
Stallergenes and ActoGenix to develop new class of oral allergy treatments
Read More
FUJIFILM Pharma signs an agreement with Merck Serono for Saizen
Read More
Yabao Pharmaceutical and MRC Technology collaborate to discover Parkinson's disease drugs
Read More
In vivo data presented for the selective LSD1 inhibitor GSK-2879552
Read More
Novel gene linked to mitochondrial myopathy
Read More
Protective effect of a vaccine against cutaneous leishmaniasis in a canine model
Read More
Merck KGaA patents new GCN2 inhibitors
Read More
U.S. investigators disclose new class II FBA inhibitors
Read More
Rociletinib shows good tolerability and durable activity in the phase I/II TIGER-X study
Read More
CRT teams up with Cancer Research UK Manchester to develop lung cancer drugs
Read More
Intra-Cellular Therapies reports additional data from phase I/II trial of ITI-007
Read More
PRO-028 and PRO-027: novel NAC analogues for cocaine addiction
Read More
Modified human cardiac stem cells overexpressing SDF-1-alpha enhance cardiac repair
Read More
Novel TGF-beta inhibitors disclosed by U.S. institutions
Read More
Brown University divulges novel selective bacterial proteasome inhibitors
Read More
Nimbus Apollo discloses new ACC2 inhibitors
Read More
University of Florida presents novel peptidomimetic antimicrobials
Read More
Santen launches TAPCOM solution for glaucoma and ocular hypertension
Read More
FDA approves Onexton gel for the treatment of acne vulgaris
Read More
ATX-F8-117 receives European orphan medicinal product designation for hemophilia A
Read More
First-in-human study of OBT-357 begins in acute myeloid leukemia
Read More
Soliris receives orphan drug designation in Japan for neuromyelitis optica
Read More
Ipsen and collaborators establish Archi-Pex joint research and innovation lab
Read More
Ocata granted European ATMP designation for RPE program for macular degeneration
Read More
Calzada to divest interest in Metabolic Pharmaceuticals
Read More
BioMarin Pharmaceutical to acquire Prosensa
Read More
Corporate name changes for Bioniche Life Sciences and Aastrom Biosciences
Read More